Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2014 Feb;347(2):167-9.
doi: 10.1097/MAJ.0000000000000243.

Irinotecan-induced immune thrombocytopenia

Barry C Mirtsching  1 , James N George, Richard H Aster, Brian R Curtis
Affiliations
Case Reports

Irinotecan-induced immune thrombocytopenia

Barry C Mirtsching et al. Am J Med Sci. 2014 Feb.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The other authors have no financial or conflict of interest to disclose.

Figures

FIGURE 1
FIGURE 1
(A) Graph of the patient’s platelet levels just before and after bevacizumab-FOLFIRI administration was resumed. Testing of patient’s serum for drug-dependent platelet antibodies by flow cytometry assay showed strong IgG antibody reactivity (MFI = 577.3) in the patient’s acute serum only in the presence of irinotecan (B) (dark histogram), but not with normal control serum and drug (C) (dark histogram). MFI = median fluorescence intensity.
See this image and copyright information in PMC

References

    1. Aster RH, Bougie DW. Drug-induced immune thrombocytopenia. N Engl J Med. 2007;357:580–7. - PubMed
    1. Fernandez MJ, Llopis I, Pastor E, et al. Immune thrombocytopenia induced by fludarabine successfully treated with rituximab. Haematologica. 2003;88:ELT02. - PubMed
    1. Khatua S, Nair CN, Ghosh K. Immune-mediated thrombocytopenia following dactinomycin therapy in a child with alveolar rhabdomyosarcoma: the unresolved issues. J Pediatr Hematol Oncol. 2004;26:777–9. - PubMed
    1. Curtis BR, Kaliszewski J, Marques MB, et al. Immune-mediated thrombocytopenia resulting from sensitivity to oxaliplatin. Am J Hematol. 2006;81:193–8. - PubMed
    1. Jardim DL, Rodrigues CA, Novis YA, et al. Oxaliplatin-related thrombocytopenia. Ann Oncol. 2012;23:1937–42. - PubMed

MeSH terms